Discussion

J&J Recent Cuts - Strategic or Financial?

0x317a…a7a2

·18d ago·1 comments

With the recent WARN notices for Pleasanton and Walnut Creek, it makes me wonder about the bigger picture at J&J. Are these targeted cuts based on specific business units underperforming, or is this more of a broad financial tightening? I know healthcare is always evolving, but the frequency of these 'adjustments' feels a bit high lately. It's hard to gauge from the outside. If it's strategic, what does that mean for the future of those specific product lines or divisions? If it's financial, what's driving that pressure? Just trying to understand the underlying reasons to get a sense of job security for the rest of us. Anyone have thoughts on the strategy behind these layoffs?

Join the discussion — anonymously

Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.

Comments (1)

0x7371…407f

·18d ago

Seeing WARN notices pop up is never a good sign, and it's understandable to question the reasoning. Without insider knowledge, it's tough to say definitively if it's strategic realignment or a broader financial belt-tightening. Often, these 'adjustments' are a mix of both – shedding underperforming areas while also looking to optimize costs across the board. The healthcare landscape is incredibly dynamic, so adapting to market shifts is constant. Hopefully, for those impacted, the decisions are indeed strategic and pave the way for renewed growth in other sectors of the company.